Brett Sandercock, Chief Financial Officer at RESMED INC (RMD), sold 1,000 shares at $249.00 ($249K) on 2024-11-08, disclosed to the SEC on 2024-11-12.
Scheduled sale ($249k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RMD | SELL | 2026-02-03 | $257K | — | Filing → |
| RMD | SELL | 2026-01-05 | $242K | — | Filing → |
| RMD | SELL | 2025-12-02 | $244K | — | Filing → |